Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Interest Expenses (2016 - 2020)

Historic Interest Expenses for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to $301000.0.

  • Larimar Therapeutics' Interest Expenses fell 3980.0% to $301000.0 in Q1 2020 from the same period last year, while for Dec 2020 it was $301000.0, marking a year-over-year decrease of 8295.58%. This contributed to the annual value of $1.8 million for FY2019, which is 695.47% down from last year.
  • Per Larimar Therapeutics' latest filing, its Interest Expenses stood at $301000.0 for Q1 2020, which was down 3980.0% from $362000.0 recorded in Q4 2019.
  • In the past 5 years, Larimar Therapeutics' Interest Expenses registered a high of $500000.0 during Q1 2019, and its lowest value of $8000.0 during Q4 2017.
  • Its 5-year average for Interest Expenses is $274058.8, with a median of $301000.0 in 2020.
  • Per our database at Business Quant, Larimar Therapeutics' Interest Expenses crashed by 9175.26% in 2017 and then surged by 613750.0% in 2018.
  • Over the past 5 years, Larimar Therapeutics' Interest Expenses (Quarter) stood at $97000.0 in 2016, then tumbled by 91.75% to $8000.0 in 2017, then soared by 6137.5% to $499000.0 in 2018, then decreased by 27.45% to $362000.0 in 2019, then decreased by 16.85% to $301000.0 in 2020.
  • Its last three reported values are $301000.0 in Q1 2020, $362000.0 for Q4 2019, and $426000.0 during Q3 2019.